Focus: Varex Imaging is a publicly traded medical device company specializing in X-ray imaging components for diagnostic and therapeutic applications across ophthalmology, neurology, and gastroenterology. The company generated $893M in revenue in FY 2025 with a profitable operating model.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Varex is a stable, profitable device manufacturer ideal for engineering and manufacturing careers, but a poor fit for pharma drug development or commercial professionals.
Help build intelligence for Varex Imaging
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Varex Imaging's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo